Improving evidence developed from population‐level experience with targeted agents

E-ISSN： 1532-6535|97|5|478-487

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.97, Iss.5, 2015-05, pp. : 478-487

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Differentiation of acute from chronic hepatitis C virus infection by nonstructural 5B deep sequencing: A population‐level tool for incidence estimation

HEPATOLOGY, Vol. 61, Iss. 6, 2015-06 ,pp. : 1842-1850

John Wiley & Sons Inc

Access to resources Recommend Favorite

Improving the outcome for children with cancer: Development of targeted new agents

CA: A CANCER JOURNAL FOR CLINICIANS, Vol. 65, Iss. 3, 2015-05 ,pp. : 212-220

John Wiley & Sons Inc

Access to resources Recommend Favorite

The quest for population‐level cancer recurrence data; current deficiencies and targets for improvement

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 6, 2015-05 ,pp. : 657-662

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reflections on the doctor–patient relationship: from evidence and experience

By Stewart Moira

British Journal of General Practice, Vol. 55, Iss. 519, 2005-10 ,pp. : 793-801

Royal College of General Practitioners

Access to resources Recommend Favorite

Using population-level time use datasets to advance knowledge of human activity, participation and health

By Hunt Eithne McKay Elizabeth A

The British Journal of Occupational Therapy, Vol. 75, Iss. 10, 2012-10 ,pp. : 478-480

College of Occupational Therapists

Access to resources Recommend Favorite